论文信息 - Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. - 字舞流文

Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.

P. Mitchell | Jie-Jin Wang | E. Rochtchina | J. Tan

[1] R. Guymer,et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? , 2005, Survey of ophthalmology.

[2] A. Hofman,et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. , 2004, Ophthalmology.

[3] A. Hofman,et al. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement , 2003, BMJ : British Medical Journal.

[4] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[5] H. Syddall,et al. Risk of macular degeneration in users of statins: cross sectional study , 2001, BMJ : British Medical Journal.

[6] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.

[7] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.